About Ainos
Ainos is a company based in San Diego (United States) founded in 1986. The company has 44 employees as of December 31, 2024. Ainos operates in a competitive market with competitors including Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.
- Headquarter San Diego, United States
- Employees 44 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ainos, Inc.
-
Annual Revenue
$20.73 K (USD)-83.02as on Dec 31, 2024
-
Net Profit
-$14.86 M (USD)-7.93as on Dec 31, 2024
-
EBITDA
-$9.04 M (USD)-12.05as on Dec 31, 2024
-
Latest Funding Round
$9 M (USD), Post-IPO
May 07, 2024
-
Investors
The Lind Partners
& 1 more
-
Employee Count
44
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ainos
Ainos is a publicly listed company on the NASDAQ with ticker symbol AIMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Ainos
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $9.0M
-
First Round
First Round
(05 Feb 2002)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Post-IPO - Ainos | Valuation |
investors |
|
| Jan, 2024 | Amount | Post-IPO - Ainos | Valuation |
investors |
|
| Sep, 2023 | Amount | Post-IPO - Ainos | Valuation |
investors |
Investors in Ainos
Ainos has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include The Lind Partners and Firebird Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
The Lind Partners is based in New York, USA.
|
Founded Year | Domain | Location | |
|
Firebird Management LLC is engaged in managing investment funds.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ainos
Financial Statements - Ainos
Ainos Comparisons
Competitors of Ainos
Ainos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services for small molecules are provided.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| domain | founded_year | HQ Location |
Generic drugs and clinical research services are provided globally.
|
|
| domain | founded_year | HQ Location |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| domain | founded_year | HQ Location |
AI powered scientific data management and workflow automation solutions
|
|
| domain | founded_year | HQ Location |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
Frequently Asked Questions about Ainos
Ainos was founded in 1986 and raised its 1st funding round 16 years after it was founded.
Ainos is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Chun Hsien Tsai is the current CEO of Ainos.
As of Dec 31, 2024, the latest employee count at Ainos is 44.
Annual revenue of Ainos is $20.73K as on Dec 31, 2024.
Ainos was founded in 1986 and is headquartered in San Diego, United States. Operations are centered in the medtech sector, with focus placed on pharmaceuticals, point-of-care testing, and low-dose interferon therapeutics. Innovative business arms are being developed, alongside new drug candidates and health supplements. Diversification efforts aim to establish leadership in these areas through ongoing research and product advancement.
Yes, Ainos is publicly traded on NASDAQ under the ticker symbol AIMD.
Ainos has 2 investors. Key investors include The Lind Partners, and Firebird Management.
The ticker symbol of Ainos is AIMD on NASDAQ.